NASHVILLE, Tenn. / Oct 04, 2023 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast:
What: | HCA Healthcare, Inc. 3Q Earnings Release Call | ||
When: | Tuesday, October 24, 2023 at 9:00 am central (10:00 am eastern) | ||
How: | Live Audio over the Internet: | ||
CLICK HERE TO REGISTER | |||
Contact:
Frank Morgan, 615-344-2688, Vice President, Investor Relations, This email address is being protected from spambots. You need JavaScript enabled to view it.
If you are unable to listen during the live webcast, the call will be archived on the web site https://investor.hcahealthcare.com/events-and-presentations/default.aspx.
| Last Trade: | US$335.55 |
| Daily Change: | -5.07 -1.49 |
| Daily Volume: | 974,226 |
| Market Cap: | US$84.990B |
February 20, 2025 February 18, 2025 October 25, 2024 | |
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MORE
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORE
